Late Restenosis after Paclitaxel-Coated Balloon Angioplasty Occurs in Patients with Drug-Eluting Stent Restenosis

Journal of the American College of Cardiology

Volumn 66, Issue 1, 2015, Pages 14-22

  Habara, Seiji ^a   Kadota, Kazushige ^a   Shimada, Takenobu ^a   Ohya, Masanobu ^a   Amano, Hidewo ^a   Izawa, Yu ^a   Kubo, Shunsuke ^a   Hyodo, Yusuke ^a   Otsuru, Suguru ^a   Hasegawa, Daiji ^a   Tada, Takeshi ^a   Tanaka, Hiroyuki ^a   Fuku, Yasushi ^a   Goto, Tsuyoshi ^a   Mitsudo, Kazuaki ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

bare metal stent restenosis; drug eluting stent restenosis; in stent restenosis; late restenosis; paclitaxel coated balloon

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE; ANTINEOPLASTIC AGENT; PACLITAXEL;

AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BIOLIMUS ELUTING CORONARY STENT; CARDIOVASCULAR PARAMETERS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RESTENOSIS; RETROSPECTIVE STUDY; SAFETY; SIROLIMUS ELUTING CORONARY STENT; TREATMENT OUTCOME; ZOTAROLIMUS ELUTING CORONARY STENT; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; CORONARY RESTENOSIS; DEVICES; DRUG ELUTING STENT; RADIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PACLITAXEL; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84937389304     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.05.002     Document Type: Article

References (21)

1. B. Scheller, Y.P. Clever, B. Kelsch, and et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
2. M. Unverdorben, C. Vallbracht, B. Cremers, and et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study EuroIntervention 2014 Aug 30 [E-pub ahead of print]
3. S. Habara, M. Iwabuchi, N. Inoue, and et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Am Heart J 166 2013 527 533
4. R. Mehran, G. Dangas, A.S. Abizaid, and et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
5. J. Wohrle, M. Zadura, S. Mobius-Winkler, and et al. SeQuentPlease World Wide Registry: clinical results of SeQuent Please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study J Am Coll Cardiol 60 2012 1733 1738
6. J.R. Nebeker, R. Virmani, C.L. Bennett, and et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project J Am Coll Cardiol 47 2006 175 181
7. R. Virmani, G. Guagliumi, A. Farb, and et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
8. M. Joner, A.V. Finn, A. Farb, and et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
9. G. Nakazawa, F. Otsuka, M. Nakano, and et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
10. F. Otsuka, M. Vorpahl, M. Nakano, and et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans Circulation 129 2014 211 223
11. N. Kuriyama, Y. Kobayashi, T. Nakama, and et al. Late Restenosis following sirolimus-eluting stent implantation J Am Coll Cardiol Intv 4 2011 123 128
12. Y. Nakagawa, T. Kimura, T. Morimoto for the j-Cypher Registry Investigators Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336
13. H. Shiomi, K. Kozuma, T. Morimoto, and et al. Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial Circ Cardiovasc Interv 7 2014 343 354
14. H. Rittger, M. Waliszewski, C. Schlundt, and et al. TCT-266 PEPCAD-DES: a randomized, multicenter, single blinded trial comparing paclitaxel coated balloon angioplasty with plain balloon angioplasty in drug-eluting-stent restenosis - 3 year results (abstr) J Am Coll Cardiol 64 11 Suppl B 2014 B77 B78
15. S. Habara, K. Mitsudo, T. Goto, and et al. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis Heart 94 2008 1162 1165
16. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Bohm, and G. Nickenig Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
17. S. Sonoda, Y. Morino, J. Ako, and et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial J Am Coll Cardiol 43 2004 1959 1963
18. R. Albiero, S. Silber, C. Di Mario for the RESCUT Investigators Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT) J Am Coll Cardiol 43 2004 943 949
19. Y. Otsuka, S. Ishiwata, T. Inada, and et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry Eur Heart J 32 2011 829 837
20. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
21. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile: a statement for health professionals Circulation 83 1991 356 362